Q: What is Javygtor used for?

Javygtor is used to treat hyperphenylalaninemia due to tetrahydrobiopterin-(BH4-) responsive phenylketonuria (PKU) (to reduce blood phenylalanine levels).

Q: How does Javygtor work?

Mechanism of Action Javygtor is a synthetic version of tetrahydrobiopterin (BH4), a substance that occurs naturally in the body. BH4 is a cofactor that is necessary for the enzyme phenylalanine hydroxylase (PAH) to work correctly. In people with phenylketonuria (PKU), the PAH enzyme is either missing or does not function well. This leads to a buildup of phenylalanine, an amino acid found in many foods, which can be harmful if levels become too high. Javygtor works by: Activating the existing PAH enzyme in the body. Helping the enzyme break down phenylalanine into other substances the body can use. Lowering the overall levels of phenylalanine in the blood. Because Javygtor relies on the presence of some working enzyme, it does not work for everyone with PKU. It is used as part of a management plan that includes a special diet restricted in phenylalanine.

Q: What are the active ingredients in Javygtor?

The active ingredient in Javygtor is sapropterin .

Q: What are the side effects of Javygtor?

Common side effects of Javygtor may include: Diarrhea Fatigue Headache Always consult with a healthcare professional about potential side effects.

Q: What drug class is Javygtor?

Javygtor belongs to the hemoglobin oxygen affinity modulator drug class.

Q: Is Javygtor safe during pregnancy and breastfeeding?

Pregnancy Data on the use of Javygtor in pregnant women are limited. However, it is well-established that poorly controlled phenylalanine levels during pregnancy, a condition known as maternal phenylketonuria (PKU), can lead to serious complications for the fetus. These risks include: miscarriage heart defects small head size (microcephaly) intellectual disabilities Animal studies using high doses of sapropterin (the active ingredient in Javygtor) did not show a clear risk of birth defects at levels similar to human doses. Because maintaining stable phenylalanine levels is critical for a healthy pregnancy, healthcare providers may prescribe Javygtor if the benefits to the mother outweigh the potential risks to the fetus. Breastfeeding It is not known whether Javygtor passes into human breast milk. In animal studies, the medication was found in the milk of lactating rats. Because of the potential for side effects in a nursing infant, a decision should be made whether to stop breastfeeding or stop the medication, taking into account how important the drug is to the mother's health. Patients should consult with their doctor to determine the best course of action.

Q: What forms and strengths does Javygtor come in?

Javygtor is supplied in the following oral forms: Tablets for oral solution: These tablets are intended to be dissolved in water or apple juice before use. They should not be swallowed whole. Powder for oral solution: This formulation is provided in packets and must be mixed with a liquid, such as water or apple juice, before being consumed.

Q: What is the FDA approval status of Javygtor?

FDA Approval and Indications The U.S. Food and Drug Administration (FDA) approved Javygtor (sapropterin dihydrochloride) to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) caused by tetrahydrobiopterin- (BH4-) responsive Phenylketonuria (PKU). It is indicated for use in conjunction with a Phe-restricted diet. Regulatory Status Javygtor is a generic version of the reference drug Kuvan. It is available in multiple forms, including oral tablets and powder for oral solution. It is classified as a synthetic form of the naturally occurring cofactor BH4, which helps the enzyme phenylalanine hydroxylase process phenylalanine. Safety Alerts and Recalls In 2024, a voluntary nationwide recall was issued for specific lots of sapropterin dihydrochloride powder for oral solution (100 mg). The recall was initiated because some packets were found to have low powder content, which could lead to a patient receiving less than the intended dose. This recall specifically affected the powder packets and not the tablet form of the medication.

Question 1

What is Javygtor?

Accepted Answer

Javygtor is a synthetic version of a naturally occurring substance in the body called tetrahydrobiopterin. This substance acts as a cofactor, which is a helper molecule that assists specific enzymes in performing their functions.

The primary role of this medication is to increase the activity of the enzyme responsible for metabolizing phenylalanine. By enhancing this enzyme's ability to process phenylalanine, the medication helps manage the concentration of this amino acid within the body.

Question 2

What is Javygtor used for?

Accepted Answer

Javygtor is used to treat hyperphenylalaninemia due to tetrahydrobiopterin-(BH4-) responsive phenylketonuria (PKU) (to reduce blood phenylalanine levels).

Question 3

How does Javygtor work?

Accepted Answer

Mechanism of Action

Javygtor is a synthetic version of tetrahydrobiopterin (BH4), a substance that occurs naturally in the body. BH4 is a cofactor that is necessary for the enzyme phenylalanine hydroxylase (PAH) to work correctly.

In people with phenylketonuria (PKU), the PAH enzyme is either missing or does not function well. This leads to a buildup of phenylalanine, an amino acid found in many foods, which can be harmful if levels become too high. Javygtor works by:

Activating the existing PAH enzyme in the body.
Helping the enzyme break down phenylalanine into other substances the body can use.
Lowering the overall levels of phenylalanine in the blood.

Because Javygtor relies on the presence of some working enzyme, it does not work for everyone with PKU. It is used as part of a management plan that includes a special diet restricted in phenylalanine.

Question 4

What are the active ingredients in Javygtor?

Accepted Answer

The active ingredient in Javygtor is sapropterin.

Question 5

What are the side effects of Javygtor?

Accepted Answer

Common side effects of Javygtor may include:

Diarrhea
Fatigue
Headache

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Javygtor?

Accepted Answer

Javygtor belongs to the hemoglobin oxygen affinity modulator drug class.

Question 7

What is the dosage of Javygtor and how do I take it?

Accepted Answer

Javygtor should be taken once daily at the same time each day. It is important to take this medication with a meal.

Administration Instructions

Tablets: Tablets may be swallowed whole or dissolved in water or apple juice as directed by a healthcare provider.
Powder: The powder must be dissolved in water or apple juice before consumption. Do not swallow the powder dry.

When dissolving the medication, stir the mixture well and drink it within the recommended timeframe. If any medicine remains in the cup, add a small amount of liquid and drink that as well to ensure the full dose is taken.

Missed Dose

If a dose is missed, it should be taken as soon as it is remembered on the same day. If it is not remembered until the next day, skip the missed dose and continue with the regular schedule. Do not take two doses on the same day.

Question 8

Is Javygtor safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Data on the use of Javygtor in pregnant women are limited. However, it is well-established that poorly controlled phenylalanine levels during pregnancy, a condition known as maternal phenylketonuria (PKU), can lead to serious complications for the fetus. These risks include:

miscarriage
heart defects
small head size (microcephaly)
intellectual disabilities

Animal studies using high doses of sapropterin (the active ingredient in Javygtor) did not show a clear risk of birth defects at levels similar to human doses. Because maintaining stable phenylalanine levels is critical for a healthy pregnancy, healthcare providers may prescribe Javygtor if the benefits to the mother outweigh the potential risks to the fetus.

Breastfeeding

It is not known whether Javygtor passes into human breast milk. In animal studies, the medication was found in the milk of lactating rats. Because of the potential for side effects in a nursing infant, a decision should be made whether to stop breastfeeding or stop the medication, taking into account how important the drug is to the mother's health. Patients should consult with their doctor to determine the best course of action.

Question 9

What forms and strengths does Javygtor come in?

Accepted Answer

Javygtor is supplied in the following oral forms:

Tablets for oral solution: These tablets are intended to be dissolved in water or apple juice before use. They should not be swallowed whole.
Powder for oral solution: This formulation is provided in packets and must be mixed with a liquid, such as water or apple juice, before being consumed.

Question 10

What is the FDA approval status of Javygtor?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved Javygtor (sapropterin dihydrochloride) to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) caused by tetrahydrobiopterin- (BH4-) responsive Phenylketonuria (PKU). It is indicated for use in conjunction with a Phe-restricted diet.

Regulatory Status

Javygtor is a generic version of the reference drug Kuvan. It is available in multiple forms, including oral tablets and powder for oral solution. It is classified as a synthetic form of the naturally occurring cofactor BH4, which helps the enzyme phenylalanine hydroxylase process phenylalanine.

Safety Alerts and Recalls

In 2024, a voluntary nationwide recall was issued for specific lots of sapropterin dihydrochloride powder for oral solution (100 mg). The recall was initiated because some packets were found to have low powder content, which could lead to a patient receiving less than the intended dose. This recall specifically affected the powder packets and not the tablet form of the medication.

Question 11

What should I know about Javygtor and cost?

Accepted Answer

Several factors determine the final price of Javygtor:

Dosage Form: Javygtor is available as 100 mg tablets and as a powder for oral solution in 100 mg and 500 mg strengths. The price may differ between these formulations.
Weight-Based Dosing: The prescribed dose is calculated based on the patient's body weight. As weight changes or as phenylalanine levels are monitored, the amount of medication needed may increase or decrease, which directly affects the total cost of treatment.
Insurance Coverage: Out-of-pocket expenses, including copays and deductibles, are determined by the patient's specific health insurance plan.

Because Javygtor is a prescription medication used for a specific metabolic condition, patients should consult with their pharmacy and insurance provider to determine the exact cost and coverage details for their situation.

Javygtor

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Javygtor

Hospitals.net Disclosure